Maraviroc, a CCR5 antagonist, prevents development of hepatocellular carcinoma in a mouse model

被引：0

作者：

Ochoa-Callejero, Laura ^{[1
]}

Perez-Martinez, Laura ^{[1
]}

Rubio-Mediavilla, Susana ^{[2
]}

Oteo, Jose A. ^{[1
]}

Martinez, Alfredo ^{[1
]}

Blanco, Jose R. ^{[1
]}

机构：

[1] Ctr Biomed Res La Rioja CIBIR, Logrono, Spain

[2] Hosp San Pedro, Logrono, Spain

来源：

CANCER RESEARCH | 2012年 / 72卷

关键词：

D O I：

10.1158/1538-7445.AM2012-LB-173

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LB-173

引用

页数：2

共 50 条

[21] Overcoming hERG affinity in the discovery of maraviroc; A CCR5 antagonist for the treatment of HIV
Price, David A.
Armour, Duncan
de Groot, Marcel
Leishman, Derek
Napier, Carolyn
Perros, Manos
Stammen, Blanda L.
Wood, Anthony
[J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2008, 8 (13) : 1140 - 1151
[22] Future of maraviroc and other CCR5 antagonists
Overton, E. Turner
Powderly, William G.
[J]. FUTURE VIROLOGY, 2006, 1 (05) : 605 - 613
[23] Profile of maraviroc: a CCR5 antagonist in the management of treatment-experienced HIV patients
Lorenzen, Thore
[J]. HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2010, 2 : 151 - 156
[24] Assessment of the pharmacokinetics, safety and tolerability of maraviroc, a novel CCR5 antagonist, in healthy volunteers
Abel, Samantha
van der Ryst, Elna
Rosario, Maria C.
Ridgway, Caroline E.
Medhurst, Christine G.
Taylor-Worth, Richard J.
Muirhead, Gary J.
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 65 : 5 - 18
[25] Allosteric Model of Maraviroc Binding to CC Chemokine Receptor 5 (CCR5)
Garcia-Perez, Javier
Rueda, Patricia
Alcami, Jose
Rognan, Didier
Arenzana-Seisdedos, Fernando
Lagane, Bernard
Kellenberger, Esther
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (38) : 33409 - 33421
[26] The Discovery and Exploratory Development of Maraviroc (UK-427,857): A Novel CCR5 Antagonist for the Treatment of HIV
CA Hitchcock
[J]. Retrovirology, 2
[27] The discovery and exploratory development of Maraviroc (UK-427,857): A novel CCR5 antagonist for the treatment of HIV
Hitchcock, C. A.
[J]. RETROVIROLOGY, 2005, 2 (Suppl 1)
[28] Maraviroc, a CCR5 Coreceptor Antagonist That Blocks Entry of Human Immunodeficiency Virus Type 1
Hunt, Joshua S.
Romanelli, Frank
[J]. PHARMACOTHERAPY, 2009, 29 (03): : 295 - 304
[29] A review of the discovery and exploratory development of Maraviroc (UK-427,857): a novel CCR5 antagonist for the treatment of HIV
Hitchcock, CA
[J]. ANTIVIRAL THERAPY, 2005, 10 (08) : L2 - L2
[30] Drug evaluation: Maraviroc, a chemokine CCR5 receptor antagonist for the treatment of HIV infection and AIDS
Meanwell, Nicholas A.
Kadow, John F.
[J]. CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2007, 8 (08) : 669 - 681

← 1 2 3 4 5 →